Zealand to Establish Research Facility in Boston to Enhance U.S. Presence

Zealand Pharma is set to open a new research facility in Boston as part of its strategy to strengthen its footprint in the United States. Bloomberg posted on X, highlighting the company's focus on expanding its operations in the U.S. market. The facility will support Zealand's efforts in developing obesity treatments, aligning with its broader mission to address global health challenges. This move is expected to bolster Zealand's research capabilities and foster collaborations within the U.S. scientific community. The expansion reflects the company's commitment to innovation and growth in the pharmaceutical sector.